Illumina shareholders have voted to oust the company’s chairman John Thompson, although chief executive Francis DeSouza has emerged from the annual meeting unscathed.
Bristol-Myers Squibb’s long-serving chief executive Giovanni Caforio has said he will retire on 1st November after almost eight years in the role and more than two decades
The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.